跳至主要內容
Peqaboo
開啟 Peqaboo
探索 Peqaboo

開啟 Peqaboo
選擇語言

繁體中文香港

來氟米特

別名: Arava

藥物類別: Immunomodulating Agent

- **試驗性用藥**:本藥物在獸醫臨床上相對屬於試驗性用藥;若發現寵物有任何異常反應(如食慾不振、嗜睡、嘔吐),請立即聯繫獸醫師。 - **安全警告**:本藥物具有致畸胎性(可能導致出生缺陷)。孕婦或計畫懷孕的婦女**絕對不可**接觸此藥物。處理藥物時請務必戴上手套,且**切勿壓碎或剝半**藥錠。 - **費用**:治療費用可能相當昂貴,但隨著學名藥的普及,價格已逐漸降低。

劑量必須由獸醫按你寵物的個別情況決定。切勿在沒有獸醫指導下給予人類藥物或其他寵物的處方藥。

Veterinary professional? See the full dosing-by-species reference on VetSheet →

用途

  • Rheumatoid arthritis
  • Immunosuppressive as part of a protocol (with cyclosporine) following organ transplant
  • Adjunctive immunosuppressive for immune-mediated hemolytic anemia
  • Treatment of systemic and cutaneous reactive histiocytosis
  • Treatment of Evans' Syndrome in a diabetic dog

給藥方式

PO

可能的副作用

  • Decreased appetite
  • Lethargy
  • Vomiting
  • Diarrhea
  • Lymphopenia
  • Anemia
  • Alopecia
  • Rash
  • Hepatotoxicity
  • Severe dermatologic reactions (Toxic Epidermal Necrolysis, Stevens-Johnson syndrome - reported in humans)
  • Gastrointestinal upset (vomiting, diarrhea, anorexia)
  • Bone marrow suppression (leukopenia, anemia, thrombocytopenia)
  • Unexplained bleeding

注意事項與禁忌

  • Pregnancy (Category X teratogen)
  • Hypersensitivity to leflunomide
  • Pre-existing immunodeficiency
  • Significant renal impairment
  • Pregnancy and lactation
  • Pre-existing severe bone marrow suppression
  • Severe hepatic impairment
  • Active severe infections
  • **Teratogenicity Warning**: Leflunomide is an FDA Category X teratogen. It must not be used in pregnant animals, and pregnant women should not handle this medication. **Prolonged Half-Life**: The active metabolite (A77 1726) can persist in the body for up to 2 years after discontinuation. If severe toxicity occurs, a washout procedure using cholestyramine or activated charcoal is required. Use with extreme caution in patients with hepatic disease, renal impairment, or pre-existing immunodeficiency.

藥物相互作用

  • Charcoal, Activated: Can increase elimination and decrease A77 1726 drug concentrations; used for rapid washout.
  • Cholestyramine: Can increase elimination and decrease A77 1726 drug concentrations; used for rapid washout.
  • Hepatotoxic Agents: Increased risk for hepatotoxicity when used concurrently.
  • Methotrexate: Increased risk of adverse effects and elevated ALT.
  • Phenytoin: Leflunomide can increase phenytoin levels.
  • Rifampin: Can increase A77 1726 peak levels.
  • Vaccines, Live Virus: Should be used with extreme caution, if at all, due to immunosuppression.
  • Warfarin: Leflunomide may increase INR.
  • Other immunosuppressants (e.g., cyclosporine, azathioprine): Increased risk of severe immunosuppression and bone marrow toxicity
  • Live vaccines: Risk of disseminated infection due to immunosuppression

常見問題

來氟米特用於寵物有甚麼用途?

- 試驗性用藥:本藥物在獸醫臨床上相對屬於試驗性用藥;若發現寵物有任何異常反應(如食慾不振、嗜睡、嘔吐),請立即聯繫獸醫師。 - 安全警告:本藥物具有致畸胎性(可能導致出生缺陷)。孕婦或計畫懷孕的婦女絕對不可接觸此藥物。處理藥物時請務必戴上手套,且切勿壓碎或剝半藥錠。 - 費用:治療費用可能相當昂貴,但隨著學名藥的普及,價格已逐漸降低。

來氟米特對我的寵物安全嗎?

劑量必須由獸醫按你寵物的個別情況決定。切勿在沒有獸醫指導下給予人類藥物或其他寵物的處方藥。

本文僅供一般健康教育,不能取代專業獸醫意見。如寵物身體不適,請諮詢獸醫。

擔心你的寵物?

Peqaboo 的 AI 助你記錄症狀、看懂化驗報告,並知道何時應求診。

下載 Peqaboo App